By Anissa Durham | Word In Black (WIB) - This is part three of “Life or Debt,” Word In Black’s drug price series, exploring the ways Black folks living
Pharmaceutical companies that manufacture insulin made headlines last year when they voluntarily agreed to provide discount cards that lower the monthly cost of insulin for many people to $35.
Did the price of insulin go down? It’s not quite that simple. On this episode of “An Arm and a Leg,” producer Emily Pisacreta explores recent changes to the cost of the diabetes medication.
Wait, Is Insulin Cheaper Now? - KFF Health News kffhealthnews.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kffhealthnews.org Daily Mail and Mail on Sunday newspapers.
Diabetics will now see a break in their out-of-pocket costs for insulin. Sanofi, one of the leading manufacturers of the hormone, joined two other major pharmaceutical companies in capping their insulin copays at $35. This comes after years of pressure by President Biden, lawmakers and activists for companies to lower their list prices. White House Correspondent Laura Barrón-López reports.